Journal of the American Academy of Dermatology
Volume 61, Issue 6 , Pages 1033-1043 , December 2009

Pain associated with aminolevulinic acid-photodynamic therapy of skin disease

  • Christine B. Warren, MD

      Affiliations

    • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Laszlo J. Karai, MD, PhD

      Affiliations

    • Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Allison Vidimos, MD, RPh

      Affiliations

    • Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Edward V. Maytin, MD, PhD

      Affiliations

    • Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
    • Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio
    • Corresponding Author InformationReprint requests: Edward V. Maytin, MD, PhD, Department of Dermatology/A61, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195.

References 

  1. Hasan T, Ortel B, Solban N, Pogue B. Photodynamic therapy of cancer. In:  Kufe DW,  Frei E,  Holland JF,  Weichselbaum RR,  Pollack RE,  Bast RC, et al. editor. Cancer medicine. 7th ed. Hamilton, Ontario, Canada: BC Decker Inc; 2006;p. 537–548
  2. Thunell S, Harper P, Brun A. Porphyrins, porphyrin metabolism and porphyrias, IV: pathophysiology of erythropoietic protoporphyria–diagnosis, care and monitoring of the patient. Scand J Clin Lab Invest. 2000;60:581–604
  3. Wennberg AM. Pain, pain relief and other practical issues in photodynamic therapy. Australas J Dermatol. 2005;46(Suppl):S3–S4discussion S23-5
  4. Grapengiesser S, Ericson M, Gudmundsson F, Larko O, Rosen A, Wennberg AM. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27:493–497
  5. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed. 2003;19:134–141
  6. Kuijpers DI, Thissen MR, Thissen CA, Neumann MH. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol. 2006;5:642–645
  7. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389:816–824
  8. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 1998;21:531–543
  9. Waldmann R, Champigny G, Bassilana F, Heurteaux C, Lazdunski M. A proton-gated cation channel involved in acid-sensing. Nature. 1997;386:173–177
  10. Kasche A, Luderschmidt S, Ring J, Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol. 2006;5:353–356
  11. Moloney FJ, Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolevulinic acid methylester with topical 5-aminolevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol. 2007;157:87–91
  12. Wiegell SR, Stender IM, Na R, Wulf HC. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol. 2003;139:1173–1177
  13. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol. 2006;54:647–651
  14. Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J. Topical application of 5-aminolevulinic acid, methyl 5-aminolevulinate and hexyl 5-aminolevulinate on normal human skin. Br J Dermatol. 2006;155:791–799
  15. Wiegell SR, Skiveren J, Philipsen PA, Wulf HC. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol. 2008;158:727–733
  16. Kleinpenning MM, Smits T, Ewalds E, van Erp PE, van de Kerkhof PC, Gerritsen MJ. Heterogeneity of fluorescence in psoriasis after application of 5-aminolevulinic acid: an immunohistochemical study. Br J Dermatol. 2006;155:539–545
  17. Zhou X, Pogue BW, Chen B, Demidenko E, Joshi R, Hoopes J, et al. Pretreatment photosensitizer dosimetry reduces variation in tumor response. Int J Radiat Oncol Biol Phys. 2006;64:1211–1220
  18. Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V, Szeimies RM, Zwingers T, Honigsmann H, et al. Topical aminolevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol. 2005;152:279–283
  19. Fritsch C, Stege H, Saalmann G, Goerz G, Ruzicka T, Krutmann J. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed. 1997;13:181–185
  20. Stender IM, Na R, Fogh H, Gluud C, Wulf HC. Photodynamic therapy with 5-aminolevulinic acid or placebo for recalcitrant foot and hand warts: randomized double-blind trial. Lancet. 2000;355:963–966
  21. Wang YS, Tay YK, Kwok C, Tan E. Photodynamic therapy with 20% aminolevulinic acid for the treatment of recalcitrant viral warts in an Asian population. Int J Dermatol. 2007;46:1180–1184
  22. Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000;142:973–978
  23. Akaraphanth R, Kanjanawanitchkul W, Gritiyarangsan P. Efficacy of ALA-PDT vs blue light in the treatment of acne. Photodermatol Photoimmunol Photomed. 2007;23:186–190
  24. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183–192
  25. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using methyl aminolevulinate: a blinded, randomized, controlled trial. Br J Dermatol. 2006;154:969–976
  26. Horfelt C, Funk J, Frohm-Nilsson M, Wiegleb Edstrom D, Wennberg AM. Topical methyl aminolevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Br J Dermatol. 2006;155:608–613
  27. Schleyer V, Radakovic-Fijan S, Karrer S, Zwingers T, Tanew A, Landthaler M, et al. Disappointing results and low tolerability of photodynamic therapy with topical 5-aminolevulinic acid in psoriasis: a randomized, double-blind phase I/II study. J Eur Acad Dermatol Venereol. 2006;20:823–828
  28. Fransson J, Ros AM. Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolevulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed. 2005;21:326–332
  29. Beattie PE, Dawe RS, Ferguson J, Ibbotson SH. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy. Clin Exp Dermatol. 2004;29:560–562
  30. Radakovic-Fijan S, Blecha-Thalhammer U, Kittler H, Honigsmann H, Tanew A. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol. 2005;53:823–827
  31. Horfelt C, Stenquist B, Larko O, Faergemann J, Wennberg AM. Photodynamic therapy for acne vulgaris: a pilot study of the dose-response and mechanism of action. Acta Derm Venereol. 2007;87:325–329
  32. Ericson MB, Sandberg C, Stenquist B, Gudmundson F, Karlsson M, Ros AM, et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol. 2004;151:1204–1212
  33. Salim A, Leman JA, McColl JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol. 2003;148:539–543
  34. Piacquadio DJ, Chen DM, Farber HF, Fowler JF, Glazer SD, Goodman JJ, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol. 2004;140:41–46
  35. Cottrell WJ, Paquette AD, Keymel KR, Foster TH, Oseroff AR. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res. 2008;14:4475–4483
  36. Alexiades-Armenakas M. Laser-mediated photodynamic therapy. Clin Dermatol. 2006;24:16–25
  37. Morton CA, Whitehurst C, Moore JV, MacKie RM. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol. 2000;143:767–772
  38. Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol. 2004;140:33–40
  39. Babilas P, Knobler R, Hummel S, Gottschaller C, Maisch T, Koller M, et al. Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol. 2007;157:111–117
  40. Wang I, Bendsoe N, Klinteberg CA, Enejder AM, Andersson-Engels S, Svanberg S, et al. Photodynamic therapy vs cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol. 2001;144:832–840
  41. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol. 2003;139:1313–1320
  42. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic cheilitis. J Drugs Dermatol. 2004;3:548–551
  43. Babilas P, Travnik R, Werner A, Landthaler M, Szeimies RM. Split-face-study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system. J Dtsch Dermatol Ges. 2008;6:25–32
  44. Babilas P, Kohl E, Maisch T, Backer H, Gross B, Branzan AL, et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol. 2006;154:712–718
  45. Wiegell SR, Haedersdal M, Philipsen PA, Eriksen P, Enk CD, Wulf HC. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol. 2008;158:740–746
  46. Haedersdal M, Togsverd-Bo K, Wiegell SR, Wulf HC. Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: a randomized controlled trial. J Am Acad Dermatol. 2008;58:387–394
  47. Palsson S, Gustafsson L, Bendsoe N, Soto Thompson M, Andersson-Engels S, Svanberg K. Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolevulinic acid. Br J Dermatol. 2003;148:1179–1188
  48. Svaasand LO. Photodynamic and photohyperthermic response of malignant tumors. Med Phys. 1985;12:455–461
  49. Warloe T, Peng Q, Moan J. Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical application of 5-aminolevulinic acid. In:  Spinelli P,  Dal Fante M,  Marchesini R editor. Photodynamic therapy and biomedical lasers. Amsterdam: Elsevier Science Publishers BV; 1992;p. 449-53
  50. Maytin EV, Wimberly JM, Anderson RR. Thermotolerance and the heat shock response in normal human keratinocytes in culture. J Invest Dermatol. 1990;95:635–642
  51. Maytin EV, Wimberly JM, Kane KS. Heat shock modulates UVB-induced cell death in human epidermal keratinocytes: evidence for a hyperthermia-inducible protective response. J Invest Dermatol. 1994;103:547–553
  52. Mandadi S, Tominaga T, Numazaki M, Murayama N, Saito N, Armati PJ, et al. Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCepsilon-mediated phosphorylation at S800. Pain. 2006;123:106–116
  53. Numazaki M, Tominaga M. Nociception and TRP channels. Curr Drug Targets CNS Neurol Disord. 2004;3:479–485
  54. Zhang H, Cang CL, Kawasaki Y, Liang LL, Zhang YQ, Ji RR, et al. Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: a novel pathway for heat hyperalgesia. J Neurosci. 2007;27:12067–12077
  55. Olah Z, Karai L, Iadarola MJ. Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem. 2001;276:31163–31170
  56. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, et al. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci U S A. 2002;99:10150–10155
  57. Siddall PJ, Cousins MJ. Neurobiology of pain. Int Anesthesiol Clin. 1997;35:1–26
  58. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77:1033–1079
  59. Glover RA, Bailey CS, Barrett KE, Wasserman SI, Gigli I. Histamine release from rodent and human mast cells induced by protoporphyrin and ultraviolet light: studies of the mechanism of mast-cell activation in erythropoietic protoporphyria. Br J Dermatol. 1990;122:501–512
  60. Lim HW, Gigli I, Wasserman SI. Differential effects of protoporphyrin and uroporphyrin on murine mast cells. J Invest Dermatol. 1987;88:281–286
  61. Rud E, Gederaas O, Hogset A, Berg K. 5-Aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol. 2000;71:640–647
  62. Huang W, Vidimos A. Topical anesthetics in dermatology. J Am Acad Dermatol. 2000;43:286–298
  63. Langan SM, Collins P. Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anesthesia with a eutectic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol. 2006;154:146–149
  64. Holmes MV, Dawe RS, Ferguson J, Ibbotson SH. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol. 2004;150:337–340
  65. Skiveren J, Haedersdal M, Philipsen PA, Wiegell SR, Wulf HC. Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study. Acta Derm Venereol. 2006;86:409–411
  66. Sandberg C, Stenquist B, Rosdahl I, Ros AM, Synnerstad I, Karlsson M, et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol. 2006;86:404–408
  67. Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain. 1999;81:135–145
  68. Halldin CB, Paoli J, Sandberg C, Ericson MB, Wennberg AM. Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy of actinic keratoses. Acta Derm Venereol. 2008;88:311–313
  69. Berking C, Herzinger T, Flaig MJ, Brenner M, Borelli C, Degitz K. The efficacy of photodynamic therapy in actinic cheilitis of the lower lip: a prospective study of 15 patients. Dermatol Surg. 2007;33:825–830
  70. Borelli C, Herzinger T, Merk K, Berking C, Kunte C, Plewig G, et al. Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: a controlled open pilot trial. Dermatol Surg. 2007;33:314–318
  71. Paoli J, Halldin C, Ericson MB, Wennberg AM. Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses. Clin Exp Dermatol. 2008;33:559–564
  72. Pagliaro J, Elliott T, Bulsara M, King C, Vinciullo C. Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen's disease: an effective addition to treatment; a pilot study. Dermatol Surg. 2004;30:63–66
  73. Stender IM, Borgbjerg FM, Villumsen J, Lock-Andersen J, Wulf HC. Pain induced by photodynamic therapy of warts. Photodermatol Photoimmunol Photomed. 2006;22:304–309
  74. Goldman MP, Merial-Kieny C, Nocera T, Mery S. Comparative benefit of two thermal spring waters after photodynamic therapy procedure. J Cosmet Dermatol. 2007;6:31–35
  75. Leff DR, Nortley M, Dang V, Bhutiani RP. The effect of local cooling on pain perception during infiltration of local anesthetic agents, a prospective randomized controlled trial. Anaesthesia. 2007;62:677–682
  76. Voets T, Droogmans G, Wissenbach U, Janssens A, Flockerzi V, Nilius B. The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature. 2004;430:748–754
  77. Bautista DM, Siemens J, Glazer JM, Tsuruda PR, Basbaum AI, Stucky CL, et al. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature. 2007;448:204–208
  78. Colburn RW, Lubin ML, Stone DJ, Wang Y, Lawrence D, D'Andrea MR, et al. Attenuated cold sensitivity in TRPM8 null mice. Neuron. 2007;54:379–386
  79. Dhaka A, Murray AN, Mathur J, Earley TJ, Petrus MJ, Patapoutian A. TRPM8 is required for cold sensation in mice. Neuron. 2007;54:371–378
  80. Proudfoot CJ, Garry EM, Cottrell DF, Rosie R, Anderson H, Robertson DC, et al. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr Biol. 2006;16:1591–1605

 Supported by National Institues of Health/National Cancer Institute grant CA84203.

 Conflicts of interest: None declared.

PII: S0190-9622(09)00391-0

doi: 10.1016/j.jaad.2009.03.048

Journal of the American Academy of Dermatology
Volume 61, Issue 6 , Pages 1033-1043 , December 2009

Article Tools